Compositions and methods for modulating cellular NF-.kappa.B activation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 3, 1999
Grant Date -
N/A
app pub date -
Feb 18, 1997
filing date -
Feb 18, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Compositions and methods for modulating the activation of nuclear factor .kappa.B (NF-.kappa.B) are provided. The compositions comprise one or more agents that modulate ubiquitination of phosphorylated I.kappa.B.alpha. and/or I.kappa.B.beta.. Such compositions may be used for treating diseases associated with NF-.kappa.B activation. Modulating agents include peptides that comprise a recognition domain for E3 ubiquitin ligase.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully